[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-365819-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-365819-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","genes-driving-three-dimensional-growth-of-immortalized-cells-and-cancer","Genes driving three-dimensional growth of immortalized cells and cancer","","Unchecked growth in three dimensions (3D) marks immortalized cells on the route to malignant transformation and offers a possible prevention target. CRISPR depletion screens compared 2D versus 3D cultures of HBLAK cells to identify genes specifically required for 3D growth, yielding 85 3D-specific candidates and a prioritized set of 11 bladder cancer-associated genes. MAPK1 emerged as the most robust hit, with single-gene validation showing 3D-specific inhibition and reduced tumor xenograft growth, and pharmacologic MAPK1 blockade by ulixertinib suppressing bladder cancer in 3D models and in vivo.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/genes-driving-three-dimensional-growth-of-immortalized-cells-and-cancer/365819/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/genes-driving-three-dimensional-growth-of-immortalized-cells-and-cancer/365819.png","ImageObject",300,407,{"name":42,"@type":43},"Taylor Morgan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study’s main goal?","Question",{"text":63,"@type":64},"To identify genes that disrupt 3D growth in immortalized cells while sparing 2D growth, improving specificity for cancer prevention and early therapy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were candidate genes identified?",{"text":68,"@type":64},"CRISPR depletion screens compared HBLAK cells grown in 2D versus 3D, using the Bassik DTKP deletion library targeting 2,333 genes.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is MAPK1 considered the key gene?",{"text":72,"@type":64},"MAPK1 remained relevant under pan-cancer criteria, its inhibition was specific to 3D growth in vitro, and its depletion reduced tumor xenograft growth in vivo.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},365819,1790218154,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099523885336,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nGenes driving three-dimensional growth of immortalized cells and cancer  \nMukta Basu1,6, Jin-Fen Xiao1,3,6, Saravana Kumar Kailasam Mani 1, Fangyuan Qu 1, Yongqi Lin1, Jason Duex1, Huihui Ye2, Vanessa Neang1 and Dan Theodorescu 1,4,5 ✉  \n© The Author(s) 2025  \n\n|  | Unchecked growth in three-dimensions (3D) in culture is a key feature of immortalized cells on the path to malignant transformation and hence a potential target phenotype for prevention. Also, expression of genes driving this process, but not that of 2D growth, would likely be more speciﬁc to cancer development and their inhibition would be less toxic to normal cells, many of which can grow in 2D but rarely in 3D culture. To deﬁne such genes, we compared CRISPR depletion screens performed in HBLAK, a spontaneously immortalized, non-tumorigenic human urothelial cell line, grown in 2D to those in 3D. Using the CRISPR Bassik DTKP (drug target kinase phosphatase) deletion library targeting 2,333 genes, we identiﬁed 85 genes which were speciﬁcally lost in 3D cultures. Prioritizing hits to those associated with bladder cancer in patients provided us with a set of 11 genes. Only one gene, MAPK1 remained relevant if a human pan-cancer criteria was applied. Single gene in vitro validation conﬁrmed that MAPK1 inhibition was speciﬁc to 3D growth. We also found that MAPK1 depletion led to signiﬁcant growth reductions in human tumor xenografts in vivo. Inhibition of MAPK1 by Ulixertinib, an orally active MAPK1 inhibitor, led to human bladder cancer growth inhibition in both 3D in vitro and in vivo models. In summary, screening for genes speciﬁcally driving 3D growth in immortalized cells may provide targets for both |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| prevention and early therapy in bladder and other cancers while potentially limiting therapeutic toxicity. |  |  |\n|  | Cell Death and Disease (2025)16:442; [https://doi.org/10.1038/s41419-025-07719-5](https://doi.org/10.1038/s41419-025-07719-5) |  |\n|  |  |  |\n\nINTRODUCTION  \nCancer medicine is slowly moving from precision medicine, treating established disease, to that of precision prevention, where primary and secondary prevention strategies target speciﬁc risk factors critical for transformation [1, 2] . The stepwise acquisition of changes like immortalization that culminate in a malignant tumor includes the ability to grow in three-dimensions (3D) and form colonies, which many normal cells do not possess in normal cell culture conditions [3–6] . Genetic screening using RNA interference and CRISPR are powerful tools to identify such genes. However, the utility of these approaches has been limited by gene redundancy, off-target effects, and discovering bona ﬁde therapeutic targets that have minimal toxicity to normal cells [7–14] .  \nCRISPR screening conducted in cancer cell lines grown in twodimensional (2D) conditions have revealed a number of genes related to critical cellular functions in various cancer types [15–18] . However, other investigations have revealed substantial differences in gene expression when cells are cultured in 2D versus the more biologically relevant 3D condition [19–21] . Here we build on these studies with a speciﬁc objective of deﬁning genes which interrupt the ability of 3D growth, but not 2D growth, in the context of cellular immortality, one of the hallmarks of malignant transformation [22] . We applied the Bassik-laboratory developed  \nDTKP library (Drug targets, kinase and phosphatases library), which standardizes the length of CRISPR guide RNAs (17-18 base pairs) [14, 23], to identify genes that are speciﬁc for 3D growth of HBLAK, a spontaneously immortalized, non-tumorigenic bladder cell line which is an effective model for identifying genes involved in early transformation [24] .  \nBladder cancer (BLCA) is an especially good model ","cbCaio29kDphdUlT","https://ap.wps.com/l/cbCaio29kDphdUlT","pdf",2753489,11,"English","# Introduction\n# Materials and Methods","[{\"question\":\"What is the study’s main goal?\",\"answer\":\"To identify genes that disrupt 3D growth in immortalized cells while sparing 2D growth, improving specificity for cancer prevention and early therapy.\"},{\"question\":\"How were candidate genes identified?\",\"answer\":\"CRISPR depletion screens compared HBLAK cells grown in 2D versus 3D, using the Bassik DTKP deletion library targeting 2,333 genes.\"},{\"question\":\"Why is MAPK1 considered the key gene?\",\"answer\":\"MAPK1 remained relevant under pan-cancer criteria, its inhibition was specific to 3D growth in vitro, and its depletion reduced tumor xenograft growth in vivo.\"}]","Genes driving three-dimensional growth of immortalized cells and cancer | PDF",1790162480,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9e45aad6adb6d5d7a51558f5bd9e3dc2.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fede6ffc0e81a7ff73b1f2128980eeac.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e703ffb181fc996b881ac6ea581ad7a1.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cb4adce6ff2953065e727403bd4a834a.webp",980,1301]